Danilo Wegner - Concepedia

Author

Danilo Wegner

Universität Greifswald

Also Known As

D WEGNER, D Wegner, D. Wegner, Danilo Wegner

Publications

699

Citations

H-Index

Concepts

All Affiliations

Universität Greifswald Universitätsmedizin Greifswald University of Lübeck Apogepha Arzneimittel (Germany)Dr. Pfleger Arzneimittel (Germany)

About

Danilo Wegner is an author at Universität Greifswald specializing in medicine, gastroenterology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	141
2	Gastroenterology	4	4	113
3	Health Sciences	1	1	18
4	Metabolism	1	1	68
5	Pathology	1	1	68

Danilo Wegner

Publications

670

Citations

H-Index

Page 1

	Year	Citations
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans K. May, Danilo Wegner, Ute Hecker, Clinical Pharmacology & Therapeutics	2004	165
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol Sierk Haenisch, Karen May, Danilo Wegner, Pharmacogenetics and Genomics	2008	86
Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects Jean de Gunzburg, Annie Ducher, Danilo Wegner, The Journal of Clinical Pharmacology	2014	69
The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen Werner Weitschies, Annika Bernsdorf, M Zschiesche, Pharmaceutical Research PhysiologyGastroenterologyPathologyPresystemic ProcessingMetabolism	2005	68
Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2 Nikolai Siebert, Christin Eger, Diana Seidel, mAbs	2016	56
Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins Stefan Oswald, D. Luetjohann, Danilo Wegner, Clinical Pharmacology & Therapeutics	2006	48
Simvastatin does not influence the intestinal P‐glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms Annika Bernsdorf, Danilo Wegner, Stefanie Igelbrink, British Journal of Clinical Pharmacology	2006	44
Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine Susanne Brueck, Henrike Bruckmueller, Danilo Wegner, Molecular Pharmaceutics	2019	31
Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania Eileen Moritz, Danilo Wegner, Stefan Groß, Clinica Chimica Acta MedicineSerum Sphingosine-1-phosphatePopulation-based StudyReference Intervals	2017	28
Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects Julia Kolbow, Danilo Wegner, Stefan Oswald, The Journal of Clinical Pharmacology Pain DisordersColon Transit TimeHealthy SubjectsGastrointestinal PharmacologyPain Medicine	2015	18

Page 1